glp-1 receptor agonists effects on cardiovascular risk reduction and mortality outcomes with vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Cardiovascular Effects and Tolerability of
Description
These medications, which mimic hormones that regulate appetite, vary in their formulation, dosing schedules, and approved uses
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF (2000) Osteoarthritis: new insights
That includes nausea, reflux, and dehydration risk
StenlidRCereniusSYManellHKkemre AydinBMrwaldKGomahrJet al
